Dr. Reddy's makes a mark in the US generics market

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 percent. Dr. Reddy's generic version of fondaparinux, used for prophylax...Read more

eHealth Access redefines healthcare in India

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

India-based start-up, eHealth Access (formely known as DialurDoctor) was established in the city of Hyderabad in 2010. Since its inception, the firm has revolutionized the healthcare space ...Read more

The breakthrough really is to explore new chemical classes for TB treatment'

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2012

Novartis Institute for Tropical Diseases (NITD) is a public-private partnership between Novartis and the Singapore Economic Development Board and involves more than 100 international scient...Read more

Aurobindo Pharma revamps strategy to accelerate growth

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo has developed its market base in over 125 countries across the globe ...Read more

Video message from women leaders in bioscience

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

We come across several women in the field of biosciences at the graduation and post-graduation level of education. However, there are only those select few who are able to climb the ladder ...Read more

Challenge No 6: Regulatory hurdles

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

The regulatory environment for life sciences companies is known for its challenging nature. The framework is confusing and at times overshoots the understandable need to protect patients wi...Read more

Nanoparticles: A unique approach to cancer treatment

Specials |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a large number of nanoparticle delivery systems have been developed for ca...Read more

Challenge No 4: Fund crunch

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small biotechnology firms related to the percentage of GDP spent on researc...Read more

XCode decodes DNA, wins BioSpectrum award

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Dr Saleem Mohammad, who founded XCode Life Sciences in December 2010, first had the idea of starting this company while he was pursuing his PhD in Bioinformatics from the University of Nebr...Read more

Dr Anu Singh: Pick biotech only if you are inspired by it

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

As Albert Einstein put it, "The world as we have created is a process of our thinking. It cannot be changed without changing our thinking." I am a firm believer that science teaches us to b...Read more

Women in life sciences – A peep into the lives of inspirational figures

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

We come across several women in the field of biotechnology at the graduation and post-graduation level of education. However, there are only those select few who are able to climb the ladde...Read more

Challenge No 9: Price cuts by govt

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Continuous drug price cuts will further squeeze margins for both multinational and domestic pharma. "The National Reform and Development Commission (NRDC), China's pricing regulatory body, ...Read more

Bioscience Industry clocks $139 bn, grows 8.37%

Specials |  Analysis | By Nandita Singh | 0 Comment | 03 Jul, 2012

The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 2009 slowdown, it was a single digit show in 2011 too. The industry reco...Read more

Challenge No 8: Partnership problems

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Finding the perfect partners in the supply chain, marketing channels and co-development collaborations to ensure maximum speed and growth of product development, finding the best partner fo...Read more

When will we stop celebrating World TB Day?

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 23 Mar, 2012

The World TB Day is celebrated every year on March 24th in order to raise awareness about the global epidemic of tuberculosis (TB) and efforts to eliminate the disease. The annual event com...Read more

10 challenges for businesses in APAC

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost & Sullivan says that by 2020, healthcare expenditure in the APAC w...Read more

Big deals: M&As in pharma

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

In 2011, the global pharmaceutical industry saw 504 mergers and acquisitions (M&A), with a total transaction value of $90 billion. Furthermore, the number of transactions in the $100 mi...Read more

BioSpectrum Asia honors Asia's best in bioscience

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning, Singapore, on March 15, 2013. Industry leaders and heads of compani...Read more